ArticleJournal of thoracic disease2021

Does denosumab offer survival benefits? -Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors.

Yenong Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.